Jointolix 750mg/50mg/250mg Tablet is a combination pharmaceutical formulation containing Glucosamine sulfate 750mg, Diacerein 50mg, and Methyl Sulfonyl Methane (MSM) 250mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine is a naturally occurring amino sugar that plays a crucial role in the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and disease-modifying properties by inhibiting interleukin-1 beta, a key mediator in cartilage degradation and inflammation. Methyl Sulfonyl Methane is an organic sulfur compound that contributes to connective tissue repair and exhibits antioxidant and anti-inflammatory effects, further supporting joint function and reducing pain and stiffness. The synergistic action of these three active ingredients aids in improving joint mobility, reducing inflammation, and slowing disease progression. Jointolix is indicated for patients with mild to moderate osteoarthritis and other joint-related conditions requiring symptomatic relief and cartilage protection. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, and potential interactions with other anti-inflammatory agents. Regular monitoring and adherence to prescribed dosages are essential for optimal therapeutic outcomes.